Minimally invasive wearable with integrated bistable compliant applicator The invention relates to a medical device (100), in particular a wearable medical device (100), for detecting at least one analyte in a body fluid, the medical device (100) comprising: a housing (101) comprising: an analyte sensor (105) having an insertable portion (111) adapted for at least partially being insertable into a body tissue of a user; an inserter (113) comprising a bistable insertion mechanism (112), wherein the bistable mechanism (112) comprises a first stable state (112a) at a first position (115) and a second stable state (112b) at a second position (114), wherein in the first position (115) of the bistable insertion mechanism (112), the analyte sensor (105) is positioned in a retracted position (105a), and wherein in the second position (114) of the bistable insertion mechanism (112), the analyte sensor (105) is positioned in an advanced position (105b), and wherein the bistable insertion mechanism (112) is configured for advancing the analyte sensor (105) from the retracted position (105a) to the advanced position (105b) during a transition from the bistable insertion mechanism (112) from the first position (115) to the second position (114), whereby the insertable portion (111) of the analyte sensor (105) can be inserted into a body tissue of a user at least partially.
A method of continuously manufacturing a template (112) for a working electrode (114), a plurality of working electrodes (114), wherein each working electrode (114) is based on the template (112) for the working electrode (114) as produced by the method, and a continuous monitoring system comprising at least one working electrode (114) from the plurality of the working electrodes (114) are disclosed. The method comprises: • i. providing a continuous carbon-coated substrate (116); and • ii. forming a continuous line (120) of at least one enzyme-wired hydrogel compound (122) on the carbon-coated substrate (116) by using a continuous reel-to-reel coating process, whereby the continuous line (120) has a lateral width (132) of 0.2 mm to 3 mm and a mean thickness (134) of 2 μm to 40 μm.
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
C12Q 1/00 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions
A method of continuously manufacturing a template (112) for a reference electrode or a combined counter electrode and reference electrode (114), a plurality of reference electrodes or combined counter electrodes and reference electrodes (114), wherein each electrode is based on the template (112) for the respective electrode as produced by the method, and a continuous monitoring system comprising at least one reference electrode or combined counter electrode and reference electrode (114) from the plurality of the reference electrodes or the combined counter electrodes and reference electrodes (114) are disclosed. The method comprises: • i. providing a continuous electrically conductive substrate (116); and • ii. applying a paste composition (122) comprising at least one binder material, silver particles and silver chloride particles to the substrate (116) by using a continuous reel-to-reel coating process, whereby a continuous line (120) having a lateral width (132) of 1 mm to 8 mm and a mean thickness (134) of 1 μm to 100 μm is formed.
The present invention refers to a body-wearable medical device (110) comprising a base (112) configured for supporting at least one component of the body-wearable medical device (110), a plaster (114) includes a first surface (116) and a second surface (118), where the first surface (116) is arranged opposite to the second surface (118), where the first surface (116) includes an adhesive configured for adhering the plaster (114) to a user's skin, where the second surface (118) of the plaster (114) is, at least in part, laser-welded to the base (112). (Figure 1)
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61M 5/44 - Dispositifs pour faire pénétrer des agents dans le corps par introduction sous-cutanée, intravasculaire ou intramusculaireAccessoires à cet effet, p. ex. dispositifs de remplissage ou de nettoyage, appuis-bras avec des moyens pour refroidir ou pour chauffer les dispositifs ou les agents
The present invention relates to a sensor for determining a volatile organic compound (volatile compound sensor) configured for determining at least one volatile organic compound in a gaseous sample of a subject, wherein the volatile compound sensor comprises at least one substrate membrane and a plurality of receptors configured to interact with one or more volatile organic compounds, wherein the plurality of receptors are immobilized on various sites of a surface of the substrate membrane, and wherein the surface of the substrate membrane has an arithmetic mean height of at least 0.04 µm, and to systems, methods, and uses related thereto.
G01N 33/543 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet avec un support insoluble pour l'immobilisation de composés immunochimiques
G01N 33/497 - Analyse physique de matériau biologique de matériau biologique gazeux, p. ex. de l'haleine
6.
A TEMPERATURE-CONTROL MOUNT AND A TEMPERATURE-CONTROL BOX FOR RECEIVING A TEST ELEMENT AND AN ANALYTICAL MEASUREMENT METHOD
The invention relates to a temperature-control mount (10) for receiving a strip-like test element (12) having an optical reagent test zone (22) to which a sample of bodily fluid can be applied by a proband for self-testing, the temperature-control mount (10) comprising a flat base plate (40) adapted to support a single test element (12), a thermal element (16) arranged on the base plate (40) in a stacked configuration and configured for providing heating power and/or cooling power to the test element (12) when mounted thereupon, a positioning unit (18) adapted to ensure a predefined alignment of the test element (12) on the thermal element (16), a controller (20) configured for temperature control at least of the test zone (22) via the thermal element (16) and a power supply (24) to deliver electrical energy to the thermal element (16) and the controller (20).
Devices and computer-implemented methods for guiding positioning of a wearable device (116) on a user (112) are disclosed. The wearable device (116) comprises at least one motion sensor (118), wherein the method comprises using a mobile device (114) comprising at least one camera (120) and at least one display device (122), wherein the method comprises the following steps: i) receiving motion data from the motion sensor (118) of the wearable device (116) in a starting position of the wearable device (116); ii) receiving image data of at least a part of a chest of the user (112) and at least a part of the wearable device (116) from the camera (120) of the mobile device (114); iii) determining a target positioning area for positioning the wearable device (116) on the chest of the user (112); iv) determining a direction of motion of the wearable device (116) towards the target positioning area using the motion data from the motion sensor (118) of the wearable device (116) in the starting position and the target positioning area; v) providing guiding signals (128) via the display device (122) of the mobile device (114) indicating the direction of motion; and vi) providing at least one signal of confirmation via the wearable device (116) in case the wearable device (116) is in the target positioning area.
Roche: P38954-WO-1 - 35 - ABSTRACT A method for biomarker prediction has been developed. The method includes providing a set of program instructions which receive data corresponding to at least one measurement of a biomarker value in a body of a user, generate a first prediction of a future value of the biomarker in the body of the user based on the at least one measurement applied to a physics- based model, generate an estimated error of the first prediction based on the at least one measurement using a trained machine learning model, correct the first prediction based on the estimated error to generate a second prediction of the future value of the biomarker in the body of the user, and generate an output indicating the second prediction of the future value of the biomarker in the body of the user.
G16H 20/10 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients
G16H 50/70 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour extraire des données médicales, p. ex. pour analyser les cas antérieurs d’autres patients
9.
COMPUTER IMPLEMENTED METHOD FOR STORING INCOMING DATA PROVIDED AT AN INPUT INTERFACE AND CORRESPONDING WEARABLE DEVICE
The invention relates to a computer implemented method (10) for storing incoming data (16) provided at an input interface (14) comprising: allocating at least three memory areas (M1,M2,M3,M4,M5) of specified sizes in a storage (12); associating each of the subsequent memory areas with a data aggregation scheme (D2,D3,D4,D5) having an increasing data compression rate; feeding the incoming data (16) to the sequence of memory areas by losslessly storing the incoming data (16) in the first memory area, wherein in case the occupancy of a memory area exceeds a maximum capacity, a portion of the data stored in this memory area is processed using the data aggregation scheme associated with the subsequent memory area and moved to the subsequent memory area or is discarded (22) from the last one. The invention also relates to a wearable device, in particular, a cardiac motion sensor.
Embodiments are described herein for updating communication parameter sets between a peripheral medical monitoring device and a central medical monitoring device. The central medical monitoring device may identify a triggering event for updating a communication parameter set related to RF communications between the peripheral medical monitoring device and the central medical monitoring device. The central medical monitoring device may collect system specification information related to at least one of the peripheral medical monitoring device or the central medical monitoring device and transmit a request for the updated communication parameter set that includes at least a portion of the system specification information. The central medical monitoring device may receive a response comprising the updated communication parameter set that is compatible with the at least the peripheral medical monitoring device or the central medical monitoring device having the at least the portion of the system specification information.
G16H 40/67 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement à distance
11.
COMPUTER-IMPLEMENTED METHOD FOR DETECTING A FOOD INTAKE OF A USER
A computer-implemented method for detecting a food intake of a user (112) is proposed. The method comprising: a. (122) retrieving motion data generated by a wearable chest motion sensor (110) worn by the user (112); b. (124) determining a swallowing motion pattern by evaluating the motion data; and c. (126) generating a food intake event signal comprising at least information regarding a time of the swallowing motion pattern, wherein the method comprises determining an indicator for meal size (138) and/or an indicator for meal quality (140) by using a pre-defined relationship between the number of detected swallowing events within a time range from the first swallowing event to the last swallowing event and the meal size and/or meal quality.
A continuous analyte sensor system (110) is disclosed, comprising: − an analyte sensor (114) comprising an insertable portion (116) adapted for being at least partially inserted into a body tissue of a user, wherein the analyte sensor (114) is configured for detecting an analyte in the body tissue of the user; − an electronics unit (118) configured for being electrically connected to the analyte sensor (114); and − an insertion device (122) configured for inserting the insertable portion (116) of the analyte sensor (114) into the body tissue of the user, wherein the insertion device (122) comprises a housing (124), a protective cap (126) and a sterile compartment (112), wherein the sterile compartment (112) encloses at least the analyte sensor (114) and a removable insertion component (128), wherein the insertable portion (116) of the analyte sensor (114) is at least partially placed inside the removable insertion component (128), wherein the sterile compartment (112) comprises a sealed opening (130) and at least one opening mechanism (132) configured for releasing the sealed opening (130), wherein the opening mechanism (132) is configured for interacting with the insertion device (122) such that a use of the insertion device (122) releases the sealed opening (130) of the sterile compartment (112), wherein the released sealed opening (130) is configured for enabling electrically connecting the analyte sensor (114) to the electronics unit (118) upon insertion of the insertable portion (116) of the analyte sensor (114) into the body tissue of the user.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1459 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des capteurs optiques, p. ex. des oxymètres à photométrie spectrale invasifs, p. ex. introduits dans le corps par un cathéter
A61B 5/1473 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques invasifs, p. ex. introduits dans le corps par un cathéter
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
13.
METHOD FOR DETERMINING A STATE OF AN ELECTRODE OF AN ELECTROCHEMICAL ANALYTE SENSOR
Method for determining a state of an electrode of an electrochemical analyte sensor, wherein the analyte sensor comprises a first electrode, a second electrode, a mediator and a sensing component, wherein the mediator is in contact with the first electrode and the sensing component, wherein the sensing component can react with an analyte, wherein the mediator can be oxidized or reduced at the first electrode, the method comprising the steps: Operating the first electrode in an open circuit mode; Polarizing the first electrode and measuring a current between the first and the second electrode as a function of time; Determining the state of the second electrode based on the measured current.
An insertion device (110) for inserting at least one insertable part of a medical device (112) into a body tissue (114) of a subject along an insertion axis (116) is disclosed. The insertion device (110) comprises an insertion tool (117), a cap (122), an insertion sleeve (124) and a guide sleeve (126) configured for guiding the insertion sleeve (124) therein, wherein the insertion sleeve (124) and/or the cap (122) in conjunction with the guide sleeve (126) form at least one friction pairing (128) comprising at least one elastic member (130) and at least one profile member (132), wherein at least one of the cap (122) and the insertion sleeve (124) comprises one of the at least one elastic member (130) and the at least one profile member (132) of the friction pairing (128) and wherein the guide sleeve (126) comprises the at least one other of the at least one elastic member (130) and the at least one profile member (132) of the friction pairing (128), wherein, for inserting the at least one insertable part of the medical device (112), the cap (122), the insertion tool (117) and the insertion sleeve (124) are configured to perform a movement (138) relative to the guide sleeve (126) from a distal position (134) to a proximal position (136) in a telescopic fashion, wherein the friction pairing (128), in response to an insertion force (140) acting on one or more of the cap (122) and the insertion sleeve (124) in a direction parallel to the insertion axis (116), is configured to provide a friction force changing with advancing of the movement (138) of one or more of the cap (122) and the insertion sleeve (124) from the distal position (134) to the proximal position (136), wherein in the distal position (136), the elastic member (130) and the profile member (132) of the at least one friction pairing (128) are spaced apart from each other, wherein one or both of the elastic member and the profile member comprises at least one material having a friction coefficient μ of 0.04 ≤ μ ≤ 0.12, specifically 0.06 ≤ μ ≤ 0.08. Further disclosed are an insertion system (111) and a method of inserting at least one insertable part of a medical device (112) into a body tissue (114) of a subject.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
A61B 17/00 - Instruments, dispositifs ou procédés chirurgicaux
A61M 5/00 - Dispositifs pour faire pénétrer des agents dans le corps par introduction sous-cutanée, intravasculaire ou intramusculaireAccessoires à cet effet, p. ex. dispositifs de remplissage ou de nettoyage, appuis-bras
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
The present invention relates to a computer-implemented method for determining a position of a wearable sensor patch (182) in a horizontal direction, wherein the wearable sensor patch (182) is positioned on a user's chest, wherein the wearable sensor patch (182) comprises at least one acceleration sensor (182) configured for generating acceleration sensor data, the method comprising: receiving the acceleration sensor data, wherein the acceleration sensor data is related to a walking movement of the user (196), wherein the acceleration sensor data comprises data related to the user walking in a forward or a backward direction during at least one left turn of the user and at least one right turn of the user, determining at least one left turn of the user (196) and at least one right turn of the user (196) while the user (196) is moving in a forward or a backward direction by evaluating the acceleration sensor data and, thereby, generating turn data, and determining a horizontal position of the wearable sensor patch (182) on the user's chest by evaluating the turn data, preferably wherein the horizontal position is determined relative to a horizontal center of the user's chest, wherein comparing the acceleration sensor data related to the at least one left turn and the acceleration sensor data related to the at least one right turn to each other is performed in order to determine an asymmetry in the turn data that is introduced due to a positioning of the wearable sensor patch in a horizontal direction that does not coincide with the horizontal center of the user's chest.
A61B 5/02 - Détection, mesure ou enregistrement en vue de l'évaluation du système cardio-vasculaire, p. ex. mesure du pouls, du rythme cardiaque, de la pression sanguine ou du débit sanguin
A61B 5/11 - Mesure du mouvement du corps entier ou de parties de celui-ci, p. ex. tremblement de la tête ou des mains ou mobilité d'un membre
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/06 - Dispositifs autres que ceux à radiation, pour détecter ou localiser les corps étrangers
16.
METHODS AND DEVICE FOR DETERMINING DATA RELATED TO A BODY FUNCTION
A computer-implemented method for operating a body-worn sensor device (178) configured to be body-worn by a user, wherein the body-worn sensor device (178) comprises a measurement sensor (184) configured for generating sensor data from the user, the method comprising: - receiving, by the body-worn sensor device (178), the sensor data from the measurement sensor (184); - initiating, by the body-worn sensor device (178), a wireless connection between the body-worn sensor device (178) and a main receiving device (180) in order to transfer at least a portion of the sensor data to the main receiving device (180) via an established wireless connection between the body-worn sensor device (178) and the main receiving device (180); - determining, by the body-worn sensor device (178), whether the initiated wireless connection between the body-worn sensor device (178) and the main receiving device (180) is established or is not established; - initiating, by the body-worn sensor device (178), a further wireless connection between the body-worn sensor device (178) and at least one further receiving device (182) in order to transfer at least the portion of the sensor data to the further receiving device (182) via the established further wireless connection between the body-worn sensor device (178) and the at least one further receiving device (182) when the initiated wireless connection between the body-worn sensor device (178) and the main receiving device (180) is not established; - transmitting, by the body-worn sensor device (178), at least a portion of the sensor data to the further receiving device (182) when the wireless connection between the body-worn sensor device (178) and the further receiving device (182) is established, wherein at least the portion of the sensor data is transmitted in order to store at least the portion of the sensor data on a storage device (196) comprised by the further receiving device.
The present invention relates in a first aspect to an electrode for an analyte sensor, comprising a layer, which comprises silver chloride (AgCl) and a thermoplastic polyurethane, wherein the thermoplastic polyurethane is obtained or obtainable from an aliphatic polyisocyanate and a polyether polyol. A second aspect of the invention relates to an analyte sensor comprising an electrode of the first aspect of the invention. In a third aspect, the invention is directed to a method for manufacturing an electrode of an analyte sensor. A fourth aspect of the invention is directed to an electrode of an analyte sensor, obtained or obtainable from the method of the second aspect of the invention. In a fifth aspect, the invention is related to a method for manufacturing an analyte sensor as of the second aspect. A sixth aspect of the invention is directed to an analyte sensor, obtained or obtainable from the method of the fifth aspect of the invention. A seventh aspect of the invention is directed to a use of an analyte sensor of the sixth aspect for detecting at least one analyte.
The present invention relates to a computer-implemented analytical measurement method for detecting a first analyte and a second analyte in a single sample of a bodily fluid, - wherein the first analyte is detectable from a first reagent test region (25) of a hybrid test element (40), the first reagent test region being configured for performing an optical detection reaction in the presence of the first analyte; - wherein the second analyte is detectable from a second reagent test region (26) of the hybrid test element, the second reagent test region being configured for performing an electrochemical detection reaction in the presence of the second analyte; and - wherein the first analyte is detectable from the first reagent test region, by using a camera (64) of a mobile device (60), when the hybrid test element is connected to an electrochemical reader unit (70); the method comprising: i) receiving an image captured by the camera of the mobile device, the image comprising a part of the first reagent test region having a first part of the single sample of the bodily fluid applied thereto; the image being captured when the hybrid test element is connected to an electrochemical reader unit; and ii) detecting the first analyte by using the image received in step i); and iii) detecting the second analyte by iii.a) using the image received in step i), the image further comprising a part of the electrochemical reader unit having an optically detectable indicator element (78) which is indicative of the electrochemical detection reaction; or iii.b) using a wireless signal received from the electrochemical reader unit (transmission unit 82), the wireless signal being indicative of the electrochemical detection reaction; wherein the second reagent test region has a second part of the single sample of the bodily fluid applied thereto.
G01N 33/52 - Utilisation de composés ou de compositions pour des recherches colorimétriques, spectrophotométriques ou fluorométriques, p. ex. utilisation de bandes de papier indicateur
G01N 33/543 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet avec un support insoluble pour l'immobilisation de composés immunochimiques
G16H 30/00 - TIC spécialement adaptées au maniement ou au traitement d’images médicales
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
19.
AN IN VIVO ANALYTE SENSOR AND A METHOD OF MANUFACTURING AN IN VIVO ANALYTE SENSOR
The present disclosure refers to an in vivo analyte sensor, comprising: a substrate (20); a conductive layer (21) disposed over at least a portion of the substrate (20); a sensing layer (24) disposed formed on the conductive layer (21), wherein the sensin\g layer (24) forms a sensing area configured to generate one or more signals identifying a monitored analyte level after insertion of the analyte sensor and when maintained in fluid contact with interstitial fluid; and a membrane layer (25) formed at least on the sensing layer (24). The sensing layer (24) is formed with an area sensitivity of 0,2 to 1,5 nA/(mqx/dL) mm2 within the sensing area. Further, a method of manufacturing an in vivo analyte sensor is provided.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
20.
COMPUTER IMPLEMENTED METHOD FOR DETECTING AN OPERATION STATUS OF AN ANALYTE SENSOR FOR CONTINUOUS ANALYTE MONITORING, COMPUTER SYSTEM, COMPUTER PROGRAM PRODUCT, AND CONTINUOUS GLUCOSE MONITORING SYSTEM
The present disclosure refers to a computer implemented method for detecting an operation status of an analyte sensor (10) for continuous monitoring an analyte, comprising: receiving continuous monitoring data for an analyte detected by an analyte sensor (10); detecting a loss of sensitivity for the analyte sensor (10), comprising determining a sensitivity indicator indicative of a sensor sensitivity of the analyte sensor (10) from the continuous monitoring data, providing a critical measure for the sensitivity indicator, and determining the loss of sensitivity for the analyte sensor (10), if the sensitivity indicator matches the critical measure for the sensitivity indicator; and detecting a defect status for the analyte sensor (10), comprising receiving an impedance value indicative of an impedance measured for the analyte sensor (10), providing a critical measure for the impedance of the analyte sensor (10), and determining the defect status for the analyte sensor (10), if the impedance value matches the critical measure for the impedance of the analyte sensor (10). A failure of the analyte sensor (10) is detected if for the analyte sensor (10) at least one of the loss of sensitivity and the defect status is determined, and, in response to detecting the failure of the analyte sensor (10), at least one of providing failure data indicative of the failure of the analyte sensor (10) and deactivating the analyte sensor (10) is conducted. Further, a computer system, a computer program product, and a continuous glucose monitoring system are provided.
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
A61B 5/1495 - Étalonnage ou test des sondes in vivo
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
21.
A CONTINUOUS ANALYTE SENSOR HAVING IMPROVED BENDING PROPERTIES
The present invention relates to an analyte sensor comprising an in-vivo portion for insertion into the body of a user and an ex-vivo portion for attachment to the external part of an analyte monitoring device. The in-vivo portion and the ex-vivo portion of the sensor are bent in an angle to each other thereby defining a bending area which is coated with a flexible thermoplastic polymer material. Further, the present invention relates to a method of manufacturing the new analyte sensor and a continuous analyte monitoring system comprising the new analyte sensor.
An analyte sensor system (114), a medical device (110), and a method for manufacturing an analyte sensor system (114) for detecting at least one analyte in a bodily fluid, the analyte sensor system (114) comprising at least one transcutaneous analyte sensor (116) having at least one flexible substrate (118); at least two sensor electrodes (120) disposed on the flexible substrate (118); and at least one contacting portion (122) having at least two sensor electrode contact pads (124) the sensor electrode contact pads (124) each being electrically connected to at least one corresponding sensor electrode (120); the analyte sensor system (114) further comprising at least one electronics unit (126) comprising at least one substrate (127) having a contacting surface (128), the electronics unit (126) comprising at least two electronics unit contact pads (124) disposed on the contacting surface (128); and the analyte sensor system (114) further comprising at least one electrically conductive elastomeric element (132), wherein the electrodes of the transcutaneous analyte sensor (116) are oriented essentially parallel to the contacting surface (128) of the electronics unit (126), wherein the contacting portion (122) of the transcutaneous analyte sensor (116) is at least partially disposed in between the electrically conductive elastomeric element (132) and the contacting surface (128) of the electronics unit (126), wherein the electrically conductive elastomeric element (132) exerts a pressure onto the contacting portion (122), thereby pressing at least one first electrode contact pad (134) of the transcutaneous analyte sensor (116) on a front side (136) of the flexible substrate (118) facing the contacting surface (128) of the electronics unit (126) towards at least one first electronics unit contact pad (138) of the electronics unit (126), thereby electrically connecting the first electrode contact pad (134) and the first electronics unit contact pad (138), wherein the electrically conductive elastomeric element (132) electrically contacts at least one second electrode contact pad (140) of the transcutaneous analyte sensor (116) on a reverse side (142) of the flexible substrate (118) facing away from the contacting surface (128) of the electronics unit (126), and wherein the electrically conductive elastomeric element (132) electrically contacts at least one second electronics unit contact pad (144) disposed on the contacting surface (128) in a laterally offset manner from the first electronics unit contact pad (138), thereby electrically connecting the second electrode contact pad (140) and the second electronics unit contact pad (144).
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
23.
METHOD FOR GENERATING SYNTHETIC DATA, SYNTHETIC DATA GENERATION DEVICE, COMPUTER PROGRAM PRODUCT, METHOD FOR PREDICTING A HEALTHCARE-RELEVANT PARAMETER AND DIABETES MANAGEMENT DEVICE
A method for generating synthetic data is provided, comprising receiving, via an input device, input data comprising input first data indicative of a first healthcare-relevant parameter, the input first data providing at least one sparse time series input signal for the first healthcare-relevant parameter, and determining, in a processing device, auxiliary first data from the input first data. The sparse time series input signal of the input first data is encoded into a dense time series input signal for the first healthcare-related parameter, the auxiliary first data providing the dense time series input signal. In the processing device, synthetic data is determined from modified input data comprising the auxiliary first data such that the synthetic data closely resembles the modified input data. Further, a corresponding synthetic data generation device, a computer program product, a method for predicting a healthcare-relevant parameter, and a diabetes management device are provided.
G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
G16H 50/50 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour la simulation ou la modélisation des troubles médicaux
G16H 50/70 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour extraire des données médicales, p. ex. pour analyser les cas antérieurs d’autres patients
A method for medical device identity and access management is proposed. The method comprising the following steps a) a medical device (112) to be controlled by a digitally connected device (116), transmitting, via an untrusted connection, to the digitally connected device (116) identifying information from the medical device (112), wherein the medical device (112) comprises at least one interface for communication with the digitally connected device (116) specified by the medical device manufacturer (120); b) a medical device identity and access management cloud backend (114) controlled by the medical device manufacturer (120), receiving an application programming interface, API, request from the digitally connected device (116), wherein the API request comprises a request for authentication information generated by the digitally connected device (116), wherein the request for authentication information comprises identifying information about the digitally connected device (116), generating, upon verifying and validating the API request and the request for authentication information, the authentication information comprising a certificate or a signature, wherein the authentication information depends on the identifying information of the digitally connected device (116) as pre-specified by the medical device manufacturer (120), signing the authentication information by using a private key of the medical device identity and access management cloud backend (114), and transmitting an API response comprising the signed authentication information to the digitally connected device (116); c) receiving via the untrusted connection at the medical device (112) from the digitally connected device (116) the signed authentication information, wherein, upon verifying and validating the authentication information at the medical device (112), an application layer security is established between the medical device (112) and the digitally connected device (116) using at least one cryptographic key exchange procedure.
H04L 67/12 - Protocoles spécialement adaptés aux environnements propriétaires ou de mise en réseau pour un usage spécial, p. ex. les réseaux médicaux, les réseaux de capteurs, les réseaux dans les véhicules ou les réseaux de mesure à distance
25.
INSERTION DEVICE AND METHOD FOR INSERTING A MEDICAL DEVICE
An insertion device (110) for inserting at least one insertable part of a medical device (112) into a body tissue (114) of a subject along an insertion axis (116) is disclosed. The insertion device (110) comprises an insertion tool (117), a cap (122), an insertion sleeve (124) and a guide sleeve (126) configured for guiding the insertion sleeve (124) therein, wherein the insertion sleeve (124) or the cap (122) in conjunction with the guide sleeve (126) form at least one resistance pairing (128) comprising at least one latch arm (130) and at least one resisting member (132), wherein at least one of the insertion sleeve (124) and the cap (122) comprises one of the at least one latch arm (130) and the at least one resisting member (132) of the resistance pairing (128) and wherein the guide sleeve (126) comprises the at least one other of the at least one latch arm (130) and the at least one resisting member (132) of the resistance pairing (128), wherein, for inserting the at least one insertable part of the medical device (112), the cap (122), the insertion tool (117), the insertion tool retractor (118) and the insertion sleeve (124) are movable relative to the guide sleeve (126) from a distal position (134) to a proximal position (136), wherein the cap (122) is movable from its distal position (134) to its proximal position (136) by an actuation force parallel to the insertion axis (116), wherein the actuation force is greater than a resistance force provided by the resistance pairing (128) in response to the actuation force. Further disclosed are an insertion system (111) and a method of inserting at least one insertable part of a medical device (112) into a body tissue (114) of a subject.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 17/20 - Instruments, dispositifs ou procédés chirurgicaux pour la vaccination ou le nettoyage de la peau avant la vaccination
A61B 5/1473 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques invasifs, p. ex. introduits dans le corps par un cathéter
A61B 5/157 - Dispositifs de prélèvement d'échantillons de sang caractérisés par des moyens intégrés pour mesurer des caractéristiques du sang
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
The invention relates to a medical device (100) for detecting at least one analyte in a body fluid, the medical device (100) comprising: an analyte sensor (104) having an insertable portion (104a) adapted for at least partially being inserted into a body tissue of a user; an insertion cannula, wherein the analyte sensor (104) is at least partially placed inside the insertion cannula; a detachable cannula head (107), wherein the insertion cannula is attached to the detachable cannula head (107), wherein the detachable cannula head (107) is configured for detachment after insertion, thereby removing the insertion cannula; at least one housing (110), wherein the housing (110) comprises at least one sensor fixation component (103) configured to at least partially receive the analyte sensor (104) and configured to at least partially receive the detachable cannula head (107); and at least one sealing element (108) configured for providing a sealing between the at least one sensor fixation component (103) and the detachable cannula head (107).
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
27.
METHODS AND DEVICES FOR CONTROLLING AN ANALYTE SENSOR DEVICE
The present invention relates to a computer-implemented method for controlling an analyte sensor device (128) configured to be body-worn by a user comprising an analyte sensor (131), the method comprising: o receiving analyte sensor (131) data generated by the analyte sensor (131); o determining a prediction time interval during which the analyte concentration of the user is predicted to be within a predetermined target range, wherein the prediction time interval is determined based on the received analyte sensor data and received event data, wherein the event data comprises data about at least one event which influences the analyte concentration in a bodily fluid of the user, in particular during the prediction time interval; and o transmitting a control signal to the analyte sensor device (128) to cause the analyte sensor device (128) to switch from an active power mode to a low power mode for the determined prediction time interval. The invention further relates to a remote controller for controlling at least one analyte sensor device (128), to a continuous analyte sensor system (130), to a computer program and to a computer-readable storage medium.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/1473 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques invasifs, p. ex. introduits dans le corps par un cathéter
The present invention relates to a computer-implemented method of obtaining an item of information on a skin condition of a user, the method comprising: i. receiving at least one image (162) of a portion of a skin of a user, wherein the image (162) has been captured by at least one camera (144) of a mobile device (132), the image (162) comprising at least one portion of the skin of the user showing the at least one skin condition; ii. obtaining at least one item of information on a skin morphology of at least one skin feature (166) comprised by the at least one portion of the skin of the user showing the at least one skin condition by evaluating the received at least one image (162) by using at least one image (162) processing algorithm, preferably wherein obtaining the at least one item of information on the skin morphology of the at least one skin feature (166) comprises comparing the at least one item of information on a skin morphology of the at least one skin feature (166) to at least one reference color (149); iii. obtaining the at least one item of information on the skin condition of the user by evaluating the at least one item of information on the skin morphology of the at least one skin feature (166) by using at least one classification algorithm.
Embodiments are described herein for delaying notifications related to disconnected analyte monitoring devices used to assist in treatment of a medical condition. The user may implement a mobile device and/or one or more analyte monitoring devices for monitoring information related to their medical condition or other health-related information. The mobile device may receive data from an analyte monitoring device when it is connected to the analyte monitoring device. The mobile device may detect a disconnection with the analyte monitoring device and delay a notification to the user related to the disconnection until a predicted period of time has elapsed without detecting a reconnection to the analyte monitoring device. The predicted period of time may be based on the analyte level of the user and/or a rate of change of the analyte level to help prevent the delay from negatively impacting the health of the user.
G16H 40/67 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement à distance
An insertion device (110) for inserting at least one insertable part of a medical device into a body tissue of a subject is disclosed, The insertion device (110) comprises at least one insertion tool (112) and at least one housing (114) configured for at least partially enclosing the insertion tool (112), the housing (114) comprising at least one distal end (116) configured for at least partially contacting a skin (118) of the subject during insertion, wherein the distal end (116) comprises at least two adaptive elements (120) arranged in parallel to each other and configured for adapting to a shape of a surface of the subject's skin (118). Further disclosed is a method of inserting at least one insertable part of a medical device into a body tissue of a subject.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
31.
COMPUTER-IMPLEMENTED METHOD FOR PREDICTING A RISK WHETHER A HYPOGLYCEMIC EVENT WILL OCCUR, DATA PROCESSING SYSTEM, COMPUTER PROGRAM, SYSTEM, AND REMOTE CONTROL
A computer-implemented method for predicting a risk whether a hypoglycemic event will occur during a prediction time interval is disclosed. The method comprises: providing user values for a plurality of machine learning input parameters, the user values determined from glucose monitoring data with glucose measurement values detected for a user before a cut-off time, the plurality of machine learning input parameters comprising: at least one first glucose measurement value determined from glucose measurements values measured within at most 10 minutes before the cut-off time, and a hypoglycemic event share value indicative of a share of previous prediction time intervals with detected hypoglycemic events out of a total number of previous prediction time intervals before the cut-off time; predicting, based on the user values and using a machine learning model, a risk whether a hypoglycemic event will occur during a prediction time interval associated with assumed sleep of the user, the machine learning model generated based on the machine learning input parameters and using historical glucose monitoring data of a user population; and generating an output based on the predicted risk. Further, a data processing system, a computer program, a system, and a remote control are disclosed.
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
G16H 50/70 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour extraire des données médicales, p. ex. pour analyser les cas antérieurs d’autres patients
32.
A SYSTEM AND METHOD FOR DYNAMIC TITRATION OF AN ANTIDIABETIC
A method and system for establishing and executing a dynamic titration protocol for administration of an antidiabetic is disclosed. The method may include establishing an initial titration protocol and then applying an aggressiveness level to the initial titration protocol to obtain an initial use titration protocol. The initial use titration protocol may then be executed with a patient and glucose monitoring data may be received from the patient. The monitoring data may be used to perform a failsafe monitoring procedure and a revised aggressiveness level and titration protocol may be determined based on the results of the failsafe monitoring.
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
33.
A SYSTEM AND METHOD FOR DYNAMIC TITRATION OF AN ANTIDIABETIC
A method and system for establishing and executing a dynamic titration protocol for administration of an antidiabetic is disclosed. The method may include establishing an initial titration protocol and then applying an aggressiveness level to the initial titration protocol to obtain an initial use titration protocol. The initial use titration protocol may then be executed with a patient and glucose monitoring data may be received from the patient. The monitoring data may be used to perform a failsafe monitoring procedure and a revised aggressiveness level and titration protocol may be determined based on the results of the failsafe monitoring.
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
A sensor assembly (110) comprising at least two sensors is discloses. The at least two sensors are selected from: at least one analyte sensor configured for detecting at least one analyte in a body fluid of a subject, wherein the analyte sensor comprises at least two first electrodes (118, 118'); and at least one electrocardiogram sensor (114) configured for detecting at least one cardiac parameter of the subject, wherein the electrocardiogram sensor (114) comprises at least two second electrodes (124. 124'), wherein at least one of the first electrodes (118') and at least one of second electrodes (124') constitute a shared electrode (128).
A61B 5/01 - Mesure de la température de parties du corps
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
A sensor assembly (124) comprising at least one in-vivo analyte sensor (110) is proposed. The analyte sensor (110) comprises at least one at least partly implantable portion. The analyte sensor (110) comprises at least two subcutaneous electrodes (116, 118) arranged at least partially at the implantable portion. At least one of the subcutaneous electrodes (116, 118) comprises at least one membrane element (120) exhibiting at least one physical property. The sensor assembly (124) comprises at least one on-skin electrode (126). The sensor assembly (124) comprises at least one electronics unit connectable to the analyte sensor (110) and the on-skin electrode (126). The electronics unit comprises at least one reference resistance. The electronics unit is configured for determining the physical property of the membrane element (120) by measuring a voltage distribution between the reference resistance and a circuit comprising the subcutaneous electrode (116, 118) comprising the membrane element (120) and the on-skin electrode (126).
A61B 5/0537 - Mesure de la composition du corps par impédance, p. ex. de l’hydratation des tissus ou de la teneur en graisses
A61B 5/0538 - Mesure de l'impédance ou de la conductivité électrique d'une partie du corps invasive, p. ex. en utilisant un cathéter
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1473 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques invasifs, p. ex. introduits dans le corps par un cathéter
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
An inserter attachment device (116) for temporarily attaching an insertion system (110) to a skin of a subject for at least the duration of an insertion of at least one insertable part of a medical device into a body tissue of the subject is disclosed. The inserter attachment device (116) comprises a frame element (118) having an attachment side (120) comprising at least one adhesive structure (122) configured for releasably attaching to the skin of the subject, wherein an adhesive strength of the adhesive structure (122) is such that the attachment is released when the insertion system (110) is lifted from the skin of the subject after the insertion is completed. Further disclosed are an insertion system (110) and a method of inserting at least one insertable part of a medical device into a body tissue of a subject.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1459 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des capteurs optiques, p. ex. des oxymètres à photométrie spectrale invasifs, p. ex. introduits dans le corps par un cathéter
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A blood glucose management system is disclosed that incorporates a blood glucose prediction model configured to predict future blood glucose measurements of a person, such as a person with diabetes, on the basis of historical blood glucose measurements, insulin bolus dosage data, and carbohydrate intake data. The historical data are pre-processed to obtain a set of features that are advantageous for predicting future blood glucose measurements using the blood glucose prediction model. The predicted future blood glucose measurements enable the blood glucose management system to provide easy-to-understand visualizations of health information. The predicted future blood glucose measurements also enable the blood glucose management system to provide early warnings of a hypoglycemic condition or hyperglycemic condition of the person.
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
A method for operating a medical monitoring system includes obtaining continuous glucose monitoring ("CGM") data. The method generates predicted CGM data and obtains bedtime data indicating sleeping hours of the person. The method generates awake alert data when (i) the data indicates that the glucose concentration level is greater than an awake threshold for longer than a predetermined awake time period, (ii) the awake time period ends before the sleeping hours, and (iii) a predetermined waiting time period has elapsed since the awake or sleeping alert data was last generated. The method generates sleeping alert data when (i) the data indicates that the glucose concentration level is greater than a sleeping threshold for longer than a predetermined sleeping time period, (ii) the sleeping time period ends during the sleeping hours, and (iii) the waiting time period has elapsed since the sleeping or the awake alert data was last generated.
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
G16H 20/70 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies mentales, p. ex. la thérapie psychologique ou le training autogène
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
The present invention relates to to a computer-implemented method, a computer program, a non-transitory computer-readable storage medium, including instructions, a data processing device, and a health management device for predicting a potential effect and/or future concentration of an analyte in a bodily fluid as well as relates to a health management system for health management of a chronic disease. In order to improve health management, a subject is notified about an at least one upcoming future event and its potential effect on the analyte concentration in the bodily fluid of the subject.
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
G16H 50/50 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour la simulation ou la modélisation des troubles médicaux
40.
ANALYTICAL METHOD FOR DETECTING AT LEAST ONE ANALYTE IN A BODILY FLUID
The present invention relates to a computer-implemented analytical method for detecting at least one analyte in a bodily fluid, the method comprising: iii) selecting at least one algorithm from a set of algorithms; and iv) applying the at least one algorithm to at least a part of the measurement data retrieved in step i); wherein, in step iii), at least one predetermined default algorithm from the set of algorithms is selected, wherein, by applying the default algorithm to at least a part of the measurement data in step iv), at least one preliminary item of information describing one or both of the presence of the analyte in the bodily fluid and the concentration of the analyte in the bodily fluid is generated, wherein the preliminary item of information is subjected to at least one sufficiency test, wherein the at least one sufficiency test comprises at least one test selected from the group consisting of: - checking if the preliminary item of information contains a value within at least one predetermined range; - checking if the preliminary item of information fulfills at least one plausibility condition; - checking if the preliminary item of information contains accuracy information fulfilling at least one accuracy condition; - checking if the preliminary item of information indicates that at least one geometrical feature has been detected in the analytical measurement data; - checking if an obtained estimate value determined by using the selected at least one predetermined default algorithm from the set of algorithms is within a concentration range for which the predetermined default algorithm is optimized and/or selected.
G16H 10/40 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données relatives aux analyses de laboratoire, p. ex. pour des analyses d’échantillon de patient
G01N 21/84 - Systèmes spécialement adaptés à des applications particulières
A continuous analyte monitoring device (110) is disclosed comprising: • an analyte sensor (112) comprising an insertable portion (116) adapted for at least partially being inserted into a body tissue of a user, wherein the analyte sensor (112) is configured for detecting an analyte in a body fluid of the user; • a removable insertion component (122) comprising an insertion cannula (124) and an insertion cannula holder (126), wherein the insertion cannula (124) is attached to the insertion cannula holder (126), wherein the insertion cannula holder (126) comprises a sealing ring (188), wherein the analyte sensor (112) is at least partially placed inside the insertion cannula (124); • a removable sterility cap (136), wherein the removable sterility cap (136) at least partially surrounds the insertable portion (116) of the analyte sensor (H2); • an electronics unit (156), wherein the analyte sensor (112) is electrically connected to the electronics unit (156); • a housing (111) comprising: - a base plate (160) being configured for attachment to a skin site of the user and an upper plate (162), wherein the base plate (160) and the upper plate (162) form an electronics compartment (154), wherein the electronics unit (156) is received in the electronics compartment (154); - a connector unit (164), wherein the connector unit (164) is integral to the base plate (160), wherein the connector unit (164) comprises an open channel (146) which at least partially surrounds at least one of the analyte sensor (112) and the removable insertion component (122), wherein the connector unit (164) further comprises a sealed channel (168) connecting the open channel (146) with the electronics compartment (154), wherein the analyte sensor (112) passes through the sealed channel (168); wherein the removable sterility cap (136), the open channel (146) of the connector unit (164) and the insertion cannula holder (126) form a sterile compartment (210) for the insertion cannula (124) and at least the insertable portion (116) of the analyte sensor (112), wherein the sealing ring (188) of the insertion cannula holder (126) is configured for sealing the sterile compartment (210).
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
42.
METHOD OF OPERATING A MEDICAL APPLICATION ON A MOBILE DEVICE HAVING AT LEAST ONE CAMERA
A method of operating a medical application on a mobile device (112) having at least one camera (114) and at least one display (116) is disclosed. The method comprises deriving at least one item of perceptivity information about a user's attention to at least one displayed critical screen and further comprises: a) receiving a predefined set of critical screens comprising critical content, wherein the critical content comprises information about one or more of, or wherein the critical content comprises a request for confirmation of one or more of: - applying of a sample of bodily fluid to at least one test field of an optical test element, - an occurred error, - injecting a bolus, - controlling an insulin pump, - delivering a medicament, - a user authentication; b) displaying to a user, on the display (116) of the mobile device (112), the at least one critical screen and deriving the at least one item of perceptivity information about the user's attention to the displayed critical screen by i) receiving at least one eye movement of the user from the camera (114), and ii) evaluating the user's eye movement, thereby deriving the item of perceptivity information; c) if the item of perceptivity information indicates that the user has perceived the critical content, prompting the user to confirm the critical content. Further, a mobile device (112) having at least one camera (114) and at least one display (116) and being configured for operating a medical application on the mobile device (112) is disclosed. Further disclosed are a kit (110), a computer program and a computer-readable storage medium.
G16H 10/40 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données relatives aux analyses de laboratoire, p. ex. pour des analyses d’échantillon de patient
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
G06F 3/01 - Dispositions d'entrée ou dispositions d'entrée et de sortie combinées pour l'interaction entre l'utilisateur et le calculateur
43.
METHOD OF DETECTING AN ANALYTE IN A SAMPLE OF BODILY FLUID
A method of detecting at least one analyte in a sample of bodily fluid by using a mobile device (112) having at least one camera (114) is disclosed. The method comprises: a) prompting a user to confirm an application of a sample of bodily fluid to at least one test field (118) of an optical test element (116), wherein the test field (118) of the optical test element (116) is configured for performing at least one optical detection reaction in the presence of the analyte in the sample of the bodily fluid, wherein the optical detection reaction is observable at least one predetermined position on the test field (118); b) receiving, from at least one sensor, at least one item of user response information about a user response, wherein the sensor is one or more of a sensor of the mobile device (112) and a sensor of a connected device connected to the mobile device (112), wherein the user response comprises one or more of - a gesture, and - an eye movement; c) deriving, from the item of user response information, at least one item of control information about the status of the application of the sample of bodily fluid; d) if the item of control information indicates that the sample of bodily fluid is applied to the test field (118) of the optical test element (116), receiving at least one image of at least a part of the test field (118) from the camera (114); and e) detecting the analyte by evaluating the at least one image. Further, a mobile device (112) having at least one camera (114) and being configured for detecting at least one analyte in a sample of bodily fluid is disclosed. Further disclosed are a kit (110), a computer program and a computer-readable storage medium.
A sensor device (110) for determining at least one physiological property of a subject (112), such as at least one analyte in a bodily fluid (114) of the subject (112) and/or at least one information on a body condition of the subject (112), is disclosed. The sensor device (110) comprises a housing (124) comprising an external housing part (126) configured to be positioned outside the subject's body (128), an internal housing part (130) configured to be positioned at least partially within a rectal cavity (132) of the subject (112), and an intermediate part (134) configured for connecting the internal housing part (130) and the external housing part (126). The intermediate part (134) tapers from the external housing part (126) to the internal housing part (130). The sensor device (110) comprises at least one sensing element (118) configured for determining the physiological property, wherein the sensing element (118) is positioned at least partially within the internal housing part (130). The sensor device further comprises at least one power source (144) configured for operating the sensing element (118) and at least one wireless communication interface (150) configured for providing measurement data obtained by the sensing element (118) to at least one further device (152).
A continuous analyte monitoring unit (110) is disclosed comprising: • an analyte sensor (112) comprising an insertable portion (116) adapted for at least partially being inserted into a body tissue of a user, wherein the analyte sensor (112) is configured for detecting an analyte in a body fluid of the user; • a removable insertion component (122) comprising an insertion cannula (124) and an insertion cannula holder (126), wherein the insertion cannula (124) is attached to the insertion cannula holder (126), wherein the analyte sensor (112) is at least partially placed inside the insertion cannula (124); • a connector unit (136), wherein the connector unit (136) comprises an open channel (138) which at least partially surrounds one or both of the analyte sensor (112) and the removable insertion component (122), wherein the connector unit (136) further comprises at least two electrical connector unit contacts (158) in electrically conductive connection with the analyte sensor (112), wherein the at least two electrical connector unit contacts (158) are configured for electrically connecting to at least two electrical housing contacts (214) of a housing (188); • a removable sterility cap (168), wherein the removable sterility cap (168) at least partially surrounds the insertable portion (116) of the analyte sensor (112); wherein the removable sterility cap (168), the connector unit (136) and the insertion cannula holder (126) form a sterile compartment (170) for the insertion cannula (124) and at least the insertable portion (116) of the analyte sensor (112).
A method for evaluating the suitability of auto-exposure settings of a mobile device for performing a color based measurement, the mobile device having at least one camera for capturing an image representative of a scene is described.
H04N 17/00 - Diagnostic, test ou mesure, ou leurs détails, pour les systèmes de télévision
H04N 23/61 - Commande des caméras ou des modules de caméras en fonction des objets reconnus
H04N 23/63 - Commande des caméras ou des modules de caméras en utilisant des viseurs électroniques
H04N 23/60 - Commande des caméras ou des modules de caméras
H04N 23/71 - Circuits d'évaluation de la variation de luminosité
H04N 23/73 - Circuits de compensation de la variation de luminosité dans la scène en influençant le temps d'exposition
A61B 10/00 - Instruments pour le prélèvement d'échantillons corporels à des fins de diagnostic Autres procédés ou instruments pour le diagnostic, p. ex. pour le diagnostic de vaccination ou la détermination du sexe ou de la période d'ovulationInstruments pour gratter la gorge
A continuous analyte monitoring device (110) is disclosed comprising: • an analyte sensor (112) comprising an insertable portion (116) adapted for at least partially being inserted into a body tissue of a user, wherein the analyte sensor (112) is configured for detecting an analyte in a body fluid of the user; • an insertion component (122) comprising an insertion cannula (124) and an insertion cannula holder (126), wherein the insertion cannula (124) is attached to the insertion cannula holder (126), wherein the analyte sensor (112) is at least partially placed inside the insertion cannula (124); • a removable sterility cap (136), wherein the removable sterility cap (136) at least partially surrounds the insertable portion (116) of the analyte sensor (112); • a housing (111), wherein the housing (111) comprises an open channel (146) which at least partially surrounds the analyte sensor (112) and the insertion component (122), wherein the housing (111) further comprises an electronics compartment (154) with an electronic unit (156) received therein; wherein the housing (111) is at least partially formed by a lower housing portion (160) and by an upper housing portion (162), wherein the housing (111) comprises a sealing channel (234) comprising an input filling port (136) and an output filling port (138), wherein the sealing channel (234) is at least partially filled with a sealing material (240) being configured for sealing an interior space (242) enclosed by the upper housing portion (162) and the lower housing portion (160); wherein the removable sterility cap (136), the open channel (146) of the housing (111) and the insertion cannula holder (126) from a sterile compartment (166) for the insertion cannula (124) and at least the insertable portion (116) of the analyte sensor (112).
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
48.
COMPUTER-IMPLEMENTED METHOD FOR EVALUATING A LATERAL FLOW TEST
A computer-implemented method for evaluating a lateral flow test (110) with regard to a presence or absence of at least one test line additionally to a control line within a test area (118) of the lateral flow test: a. receiving an image data of the test area (118) of a lateral flow test (110) generated with a camera (138) comprised by a mobile device (136), b. determining at least a direction and a width of a control line within the test area (118) of the image data, c. generating a direction selective filter based on the direction and width of the control line, wherein the direction selective filter is a digital filter to enhance and/or suppress features in an image data depending on the orientation, d. filtering the image data of step a with the direction selective filter, e. evaluating the filtered image data with regard to a presence or an absence of a test line, and f. providing a result of the lateral flow test.
A method of manufacturing at least one analyte sensor (110) for determining at least one analyte in a bodily fluid is proposed. The method comprises the steps of: A) providing at least one substrate (112) comprising a first side (114) and a second side (H6); B) providing at least one first conductive layer (122) at least partially covering the first side (114) of the substrate (112); C) providing at least one second conductive layer (124) at least partially covering at least one of the first side (114) and the second side (116); D) providing at least one working electrode (128) on the first side (114) by providing at least one working electrode material (132) at least partially covering the first conductive layer (122); E) providing at least one further electrode (142) on at least one of the first side (114) and the second side (116) by providing: at least one AgCl-comprising composition (146) at least partially covering the second conductive layer (124); and at least one protective layer (148) covering the AgCl-comprising composition (146) apart from at least one interaction area (150) accessible to the bodily fluid; F) exposing the AgCl-comprising composition (146) at least partially to ultraviolet light.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
C12Q 1/00 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions
G01N 27/30 - Électrodes, p. ex. électrodes pour testsDemi-cellules
A61B 5/1473 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques invasifs, p. ex. introduits dans le corps par un cathéter
50.
METHOD FOR DETERMINING AN ITEM OF INFORMATION ABOUT A QUALITY OF AN IMAGE
The present invention relates to a computer-implemented method for determining an item of information about a quality of an image, wherein the item of information about the quality of the image relates to a suitability of the image to be used in an analytical measurement method for detecting at least one analyte in a bodily fluid, wherein the at least one analyte is detected from at least one reagent test region of an optical test element; by using a mobile device having at least one camera, the method comprising: (i) receiving at least one image captured by using the camera, wherein the image comprises at least a part of the reagent test region of the optical test element having the sample of the bodily fluid applied thereto; (ii) deriving, from the image received in step (i), independently from one another, an image quality value QVx for each of at least two different image quality parameters QPx, selected from a pre-determined set of image quality parameters QP1 to QPn, wherein the at least two of the image quality parameters QPx, independently from one another, are configured to assess at least one of: a color characteristic of an image, and a spatial characteristic of an image; (iii) comparing each of the image quality values QVx derived in step (ii), independently from one another, to one or more pre-determined threshold values TV(QPx); and, based on the comparing, assigning, independently from one another, an individual numerical quality assessment value IAV(QPx) to each of the at least two different image quality parameters QPx of step (ii), wherein the individual numerical quality assessment values are selected from a pre-determined set of individual numerical quality assessment values; and (iv) deriving, from the individual numerical quality assessment values IAV(QPx) assigned in step (iii), an overall image quality assessment value OAV; comparing said overall image quality assessment value OAV to an overall pre-determined threshold value OTV; and, based on the comparing, determining the item of information about the quality of the image received in step (i), wherein step iv) is performed only if none of the individual numerical quality assessment values IAV(QPx) assigned in step (iii) to the image quality parameters QPx of step (ii) corresponds to a pre-determined category of an insufficient quality in respect of any of the image quality parameters QPx.
A method for generating diabetes management parameter user interfaces includes providing stored program instructions of a first diabetes management application (DMA), the first DMA configured to be stored in a memory of an electronic device and, upon execution by a processor, the first DMA is configured to generate a first output display of a plurality of diabetes management parameters corresponding to a time series of analyte data, the plurality of diabetes management parameters depicting a trend of diabetes management parameter levels over time, generate a graphical indicator of a link to a second DMA stored in the memory, and activate the second DMA in response to an input selection of the link, wherein the second DMA is configured to be executed by the processor to generate a second output display of a current-time diabetes management parameter corresponding to the time series of the analyte data stored in the memory.
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
G16H 15/00 - TIC spécialement adaptées aux rapports médicaux, p. ex. leur création ou leur transmission
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A medical device for detecting at least one physiological parameter of a user is proposed. The medical device (112) comprises: • at least one electronics unit (116); • at least one analytical sensor (136) for transdermal insertion into a body tissue of a user, the analytical sensor (136) having an insertable portion (138) configured for at least partially being inserted into the body tissue and at least one electrical connection portion (140) being electrically connected to the electronics unit (116); and • at least one housing (118) being made of at least one housing material (162), the housing (118) receiving the electronics unit (116). The analytical sensor (136), with at least the insertable portion (138), protrudes from at least one opening (152) in the housing (118). The medical device (112) further comprises at least one guiding element (156) at least partially made of at least one guiding material (170) softer than the housing material (162). The guiding element (156) at least partially surrounds the analytical sensor (136) at the opening (152). Further, a medical system (110) comprising the medical device (112) and a method of assembling a medical device (112) are proposed.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/1473 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques invasifs, p. ex. introduits dans le corps par un cathéter
53.
ELECTROCHEMICAL SENSING ELECTRODES AND BIOSENSORS AND PRODUCTION METHODS
Disclosed are methods for producing a sensing electrode in which an area of electrode material is applied to a substrate, a sensing chemistry material is applied to cover the electrode material, and a laser is used to form a laser cut the sensing chemistry material and the electrode material in a pattern to define at least a portion of the perimeter of the sensing electrode. The laser cut forms a gap physically and electrically separating the sensing chemistry material and the electrode material inside tire laser cut from the extraneous sensing chemistiy material and the electrode material outside the laser cut. The methods further provide for producing a plurality of sensing electrodes which are separated from a continuous substrate. Further disclosed are the sensing electrodes produced by such methods.
A medical device (146) for detecting an analyte in a body fluid is disclosed. The medical device (146) comprises: - an analyte sensor (110) having an insertable portion (115) adapted for at least partially being inserted into a body tissue of a user, wherein the analyte sensor (110) is configured for detecting the analyte in the body fluid, wherein the analyte sensor (110) comprises at least two conductor paths (136) configured for activating a sensor circuit, wherein the analyte sensor further comprises at least two electrodes (124) each comprising an electrode conductor path (125) configured for transmitting a sensor current for detecting the analyte; - an insertion component (147) comprising an insertion cannula (148), wherein the analyte sensor (110) is at least partially placed inside the insertion cannula (148); - an electronics unit comprising the sensor circuit; - a housing (154) having an electronics compartment (156) with the electronics unit at least partially received therein, wherein the housing (154) further comprises an open channel (170) which at least partially surrounds the analyte sensor (110) and the insertion component (147); and - a connector element (200), wherein the insertion component (147) is configured for being retracted from the open channel (170) thereby triggering an electrically contacting of the at least two conductor paths (136) of the analyte sensor (110) by the connector element (200) such that the sensor circuit is activated.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1473 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques invasifs, p. ex. introduits dans le corps par un cathéter
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
55.
MEDICAL DEVICE HAVING AN INDICATOR FIELD SENSITIVE TO AN ENVIRONMENTAL PARAMETER
Medical device having an indicator field sensitive to an environmental parameter A medical device comprising a medical tool, an indicator area connected to the medical tool and a controller connected to the medical tool, wherein the indicator area comprises an indicator field which is a part sensitive to an environmental parameter, in particular humidity or humidity changes or temperature or temperature changes, that is configured to irreversibly change its appearance at a predetermined environmental parameter condition, in particular a predetermined humidity condition or predetermined humidity change condition or predetermined temperature condition or predetermined temperature change condition, wherein the medical device is configured such that at the time of use of the medical tool, the appearance of the indicator field is determined, and wherein the controller is configured to control the function of the medical tool based upon the determined appearance of the indicator field.
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
56.
SENSOR ASSEMBLY AND METHOD FOR WAKE UP OF A SENSOR ASSEMBLY
A sensor assembly comprising at least one analyte sensor (110) configured for transdermal detecting at least one analyte is proposed. The analyte sensor (110) comprises at least two electrodes (116, 118). The sensor assembly (124) comprises at least one electronics unit (126) connectable to the analyte sensor (110). The electronics unit (126) comprises at least one wake up unit (128) configured for determining conductivity of the analyte sensor (110) and for triggering a wake up of the sensor assembly (124) depending on the determined conductivity of the analyte sensor (110).
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1468 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
A non-invasive analyte sensor (112) for on-skin wearing is described, comprising - at least one analyte-responsive layer (114) exhibiting at least one physical property depending on a quantity of the analyte, wherein the analyte-responsive layer (114) has a skin contacting surface (120) configured for directly or indirectly contacting the skin; and - at least one conversion layer (116).
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1455 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des capteurs optiques, p. ex. des oxymètres à photométrie spectrale
A method for determining a subject's analyte level is disclosed. The method comprises the steps of: • a) non-invasively detecting a first amount of at least one first volatile organic marker originating from a first source of the subject; • b) non-invasively detecting a second amount of at least the first volatile organic marker originating from a second source of the subject, wherein the second source is different from the first source; and • c) determining the subject's analyte level based on the first amount and on the second amount.
A non-invasive analyte sensor (112) is proposed, comprising at least two electrodes (114), each having a skin contacting surface (116). At least one of the electrodes (114) is a detection electrode (120). The detection electrode (120) comprises at least one analyte-responsive layer (124) and at least one conversion layer (126). At least one other of the electrodes (114) is configured as an auxiliary electrode (128) configured as either a counter, or a combined counter-reference electrode.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1468 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
60.
CALIBRATION METHOD AND ANALYTICAL METHOD OF DETECTING AN ANALYTE IN A BODILY FLUID
A calibration method is disclosed, for use in an analytical method of detecting at least one analyte in a sample of a bodily fluid by using a mobile device (110) having at least one camera (112) and at least one ambient light sensor (114), the calibration method comprising: a. providing a set of lighting conditions; and b. determining a calibration set, the calibration set comprising calibration functions (152) for each of the lighting conditions of the set of lighting conditions, each calibration function (152) providing a relationship between at least one item of optical information derived from at least one image captured with the camera (112) from at least one part of at least one test field (120) of an optical test element (118) under the respective lighting condition and a concentration of the analyte in a sample applied to the test field (120). Further disclosed is a computer-implemented analytical method and a mobile device (110), a computer program and a computer-readable storage medium for performing the analytical method.
G01N 21/84 - Systèmes spécialement adaptés à des applications particulières
G01N 21/78 - Systèmes dans lesquels le matériau est soumis à une réaction chimique, le progrès ou le résultat de la réaction étant analysé en observant l'effet sur un réactif chimique produisant un changement de couleur
61.
IDENTIFICATION METHOD AND ANALYTICAL METHOD OF DETECTING AT LEAST ONE ANALYTE IN A SAMPLE OF A BODILY FLUID
A computer-implemented identification method of identifying a user and a computer-implemented analytical method are disclosed. The identification method is configured for an analytical method of detecting at least one analyte in a sample of a bodily fluid. The identification method comprises using a mobile device (110), specifically a mobile communication device, the mobile device (110) having at least one camera (112) and at least one RFID reader device (114). The identification method comprises: a. prompting the user to identify by bringing at least one RFID identifier (116) of the user into a communication range of the RFID reader device (114); b. reading out data from the RFID identifier (116) by using the RFID reader device (114); c. validating the data read out in step b., wherein the validating comprises checking if at least one valid item of identification information of the user was successfully transferred with the data from the RFID identifier (116) to the RFID reader device (114). Further disclosed is a computer program and a computer-readable storage medium for performing any one of the methods.
G16H 10/65 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients stockées sur des supports d’enregistrement portables, p. ex. des cartes à puce, des étiquettes d’identification radio-fréquence [RFID] ou des CD
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
G16H 10/40 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données relatives aux analyses de laboratoire, p. ex. pour des analyses d’échantillon de patient
G16H 40/20 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour la gestion ou l’administration de ressources ou d’établissements de soins de santé, p. ex. pour la gestion du personnel hospitalier ou de salles d’opération
A method of titrating an antidiabetic for a patient is disclosed, along with a system for performing the method. The method includes providing a database having anonymized personal parameters for a plurality of previously managed subjects and generating cohorts from the plurality of previously managed subjects based on similarities in the anonymized personal parameters. The method further includes receiving patient specific personal parameters and identifying from the generated cohorts a patient similar cohort corresponding to the patient specific personal parameters. A titration output parameter to optimize may either be entered or computed. Based on the titration output parameter to optimize and the patient similar cohort, a customized titration protocol for the patient can then be derived.
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
G16H 20/00 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients
G16H 10/20 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des essais ou des questionnaires cliniques électroniques
G16H 50/70 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour extraire des données médicales, p. ex. pour analyser les cas antérieurs d’autres patients
A method of titrating an antidiabetic for a patient is disclosed, along with a system for performing the method. The method includes providing a database having anonymized personal parameters for a plurality of previously managed subjects and generating cohorts from the plurality of previously managed subjects based on similarities in the anonymized personal parameters. The method further includes receiving patient specific personal parameters and identifying from the generated cohorts a patient similar cohort corresponding to the patient specific personal parameters. A titration output parameter to optimize may either be entered or computed. Based on the titration output parameter to optimize and the patient similar cohort, a customized titration protocol for the patient can then be derived.
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
G16H 50/70 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour extraire des données médicales, p. ex. pour analyser les cas antérieurs d’autres patients
64.
METHOD AND MOBILE DEVICE FOR DETECTING AN ANALYTE IN A SAMPLE OF A BODILY FLUID
A computer-implemented method of detecting at least one analyte in a sample of a bodily fluid by using a mobile device (136) having at least one camera (138), the method particu- larly comprising: c. weighting the potential item of intensity information on the optical detection feature of the optical detection reaction with at least one known item of position probability information on the optical detection reaction, wherein the known item of position probability information is a probability of a potential item of intensity information on the optical detection reaction to be a valid item of intensity information on the optical detection reaction depending on the associated item of position information on the optical detection, wherein the known item of position probability information on the optical detection reaction is determined by considering the associated item of position information on the optical detection reaction, wherein the at least one known item of position probability information considers at least one tolerance in a manu- facturing process of the optical test element (110) having an influence on the at least one predetermined position of the optical detection reaction on the test field (118); d. detecting the analyte by considering the weighted potential item of intensity infor- mation on the optical detection reaction for differentiating a valid item of intensity information on the optical detection reaction from an invalid item of intensity infor- mation.
A method for medication bolus calculation has been developed. The method includes receiving physiological measurements from an analyte sensor coupled to a user, receiving data corresponding to at least one meal event including a timestamp corresponding to when a meal was consumed, identifying a missed meal event time corresponding to a meal consumed by the user but not to the timestamp of any meal event, the recommended bolus being calculated based, at least in part, upon an length of time elapsed from the missed meal event time to a current time, and generating an output message indicating the recommended bolus of the medication.
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
G16H 40/67 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement à distance
66.
MEDICAL SYSTEM AND A METHOD FOR MONITORING THE STORAGE CONDITIONS THEREOF
A medical system (110) and a method for monitoring the storage conditions of at least one medical system (110) are disclosed. The medical system (110) comprises: - at least one analyte sensor (112) for detecting at least one analyte in a bodily fluid, the analyte sensor (112) being configured for at least partial transcutaneous insertion into a body tissue (114) of a user (116); and - at least one disabling device (118) operably connected to the analyte sensor (112), the disabling device (118) comprising at least one monitoring element (120), the monitoring element (120) being configured for undergoing a change in at least one mechanical property when storage conditions of the analyte sensor (112) are outside a specification range, the mechanical property change being configured such that the transcutaneous insertion of the analyte sensor (112) into the body tissue (114) is irreversibly prevented.
A battery clip for retaining at least one battery to a circuit carrier is disclosed along with an assembly including a circuit carrier having a plurality of flexible tabs and a battery clip configured to be secured to the circuit carrier to securely retain a battery thereto for providing power to the circuit carrier. The battery clip includes a plurality of slots configured to mate with and receive the flexible tabs of the circuit carrier such that the battery clip and the circuit carrier are secured together such that a first terminal of a retained battery physically contacts and is in electrical communication with the circuit carrier's first pad, the battery clip further comprising one or more flexible conductive fingers configured to contact a second terminal of a retained battery to establish an electrical communication between the fingers and the second terminal, and wherein the battery clip comprises an electrically conductive material and establishes electrical communication between the fingers and the circuit carrier's second pad.
H01M 50/216 - Bâtis, modules ou blocs de multiples batteries ou de multiples cellules caractérisés par leur forme adaptés aux cellules en forme de bouton ou plate
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A battery clip (110) for retaining at least one battery (162) to at least one battery contact pad (152) of a circuit carrier (150) is disclosed. The battery clip (110) comprises at least one housing (112). The housing (112) comprises at least one receptacle (114) for at least partially receiving the circuit carrier (150) and the battery (162). The receptacle (114) comprises at least one opening (116) through which the battery (162) and the circuit carrier (150) are at least partially insertable. The housing (112) comprises or is at least partially formed by at least one first contact spring element (166) and by at least one second contact spring element (118). The first contact spring element (166) and the second contact spring element (118) are configured for retaining the battery (162) to the battery contact pad (152) of the circuit carrier (150). The first contact spring element (166) is configured for contacting the battery (162) being arranged on a first side (168) of the circuit carrier (150) being inserted into the receptacle (114). The second contact spring element (118) is configured for contacting a second side (170) of the circuit carrier (150) being inserted into the receptacle (114), the second side (170) opposing the first side (168).
H01M 50/216 - Bâtis, modules ou blocs de multiples batteries ou de multiples cellules caractérisés par leur forme adaptés aux cellules en forme de bouton ou plate
H01M 50/244 - Boîtiers secondairesBâtisDispositifs de suspensionDispositifs de manutentionSupports caractérisés par leur procédé de montage
H01M 50/247 - MonturesBoîtiers secondaires ou cadresBâtis, modules ou blocsDispositifs de suspensionAmortisseursDispositifs de transport ou de manutentionSupports spécialement adaptés aux dispositifs portatifs, p. ex. aux téléphones portables, aux ordinateurs, aux outils à main ou aux stimulateurs cardiaques
H01M 10/42 - Procédés ou dispositions pour assurer le fonctionnement ou l'entretien des éléments secondaires ou des demi-éléments secondaires
69.
MEDICAL DEVICE COMPRISING A TEMPERATURE SENSITIVE ACTIVATION LABEL
A medical device comprising a medical tool and an activation label connected to the medical tool, wherein the activation label comprises an activation code required for activating the medical device, the medical device comprising a controller connected to the medical tool, which is configured to receive an activation signal from a remote control device, and wherein the activation label comprises a temperature sensitive part that is configured to change its appearance at a predetermined temperature condition, in particular such that it masks at least part of the activation code if the predetermined temperature condition is reached.
G16H 40/60 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
G09F 3/00 - Étiquettes, fiches ou moyens analogues d'identification ou d'indicationSceauxTimbres-poste ou timbres analogues
70.
CUSTOMIZABLE CONTINUOUSLY UPDATED EVENT MONITORING FOR SCREENS ON COMPUTING DEVICE
A computing device may provide access to information related to the medical condition or health of the user in the form of an overlay notification when the computing device is displaying a graphical user interface. The overlay notification may be dynamically and/or continuously updated on the graphical user interface of the device in response to updated data. The overlay notification may be enabled/disabled in response to overlay notification triggering events/overlay notification removal events. When multiple types of information are to be displayed at a time, the computing device may group the information into a common overlay notification that may be updated dynamically and/or continuously in response to updated data. As the information that is provided in the overlay notification may be sensitive information, the information in the overlay notification may be prevented from being displayed until additional input is received from the user.
G16H 40/40 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour la gestion d’équipement ou de dispositifs médicaux, p. ex. pour planifier la maintenance ou les mises à jour
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
G06F 3/0481 - Techniques d’interaction fondées sur les interfaces utilisateur graphiques [GUI] fondées sur des propriétés spécifiques de l’objet d’interaction affiché ou sur un environnement basé sur les métaphores, p. ex. interaction avec des éléments du bureau telles les fenêtres ou les icônes, ou avec l’aide d’un curseur changeant de comportement ou d’aspect
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
71.
CUSTOMIZABLE CONTINUOUSLY UPDATED EVENT MONITORING FOR SCREENS ON COMPUTING DEVICE
A computing device may provide access to information related to the medical condition or health of the user in the form of an overlay notification when the computing device is displaying a graphical user interface. The overlay notification may be dynamically and/or continuously updated on the graphical user interface of the device in response to updated data. The overlay notification may be enabled/disabled in response to overlay notification triggering events/overlay notification removal events. When multiple types of information are to be displayed at a time, the computing device may group the information into a common overlay notification that may be updated dynamically and/or continuously in response to updated data. As the information that is provided in the overlay notification may be sensitive information, the information in the overlay notification may be prevented from being displayed until additional input is received from the user.
G16H 40/40 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour la gestion d’équipement ou de dispositifs médicaux, p. ex. pour planifier la maintenance ou les mises à jour
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
G06F 3/0481 - Techniques d’interaction fondées sur les interfaces utilisateur graphiques [GUI] fondées sur des propriétés spécifiques de l’objet d’interaction affiché ou sur un environnement basé sur les métaphores, p. ex. interaction avec des éléments du bureau telles les fenêtres ou les icônes, ou avec l’aide d’un curseur changeant de comportement ou d’aspect
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
72.
INSERTION TOOL FOR INSERTING AT LEAST ONE MEDICAL DEVICE INTO A BODY TISSUE
An insertion tool (114) for inserting at least one insertable part of a medical device into a body tissue of a subject is proposed. The insertion tool (114) comprises a shaft (116) configured for receiving the medical device. The shaft (116) comprises an insertable first end (118) and an adjustable second end (120).
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
A61M 5/00 - Dispositifs pour faire pénétrer des agents dans le corps par introduction sous-cutanée, intravasculaire ou intramusculaireAccessoires à cet effet, p. ex. dispositifs de remplissage ou de nettoyage, appuis-bras
A method of operating a medical monitoring system includes providing stored program instructions for a software application. The software application is configured to be stored in a non-transitory memory of a computing device. Upon execution by a processor of the computing device, the software application is configured to (i) obtain measurement data, (ii) store image data of a nonmedical image on the non-transitory memory, (iii) modify the image data based on the measurement data to generate modified image data, and (iv) render the modified image data as a modified image on a display screen of the computing device. Modifying the image data includes changing a feature of the nonmedical image to represent the measurement data.
G16H 20/00 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
74.
MEDICAL DEVICE AND METHOD FOR MONITORING INTEGRITY OF A HOUSING OF A MEDICAL DEVICE
A medical device (112) having at least one invasive portion (124) is disclosed. The medical device (112) comprises at least one housing (114) at least partially surrounding at least one tight chamber (116). The tight chamber (116) is configured for sustaining a pressure difference between at least one interior lumen (118) of the tight chamber (116) and a surrounding environment (120). The housing (114) comprises at least one deformable component (122). The housing (114) is configured such that a state of deformation of the deformable component (122) provides for a measurable indication of the pressure difference between the interior lumen (118) of the tight chamber (116) and the surrounding environment (120).
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
G01M 3/36 - Examen de l'étanchéité des structures ou ouvrages vis-à-vis d'un fluide par utilisation d'un fluide ou en faisant le vide par détection des variations dans les dimensions de la structure à tester
75.
SYSTEM AND METHOD FOR DISPLAYING AN IMAGE-BASED REPRESENTATION OF MEASUREMENT DATA
A method of operating a medical monitoring system includes providing stored program instructions for a software application. The software application is configured to be stored in a non-transitory memory of a computing device. Upon execution by a processor of the computing device, the software application is configured to (i) obtain measurement data, (ii) store image data of a nonmedical image on the non-transitory memory, (iii) modify the image data based on the measurement data to generate modified image data, and (iv) render the modified image data as a modified image on a display screen of the computing device. Modifying the image data includes changing a feature of the nonmedical image to represent the measurement data.
G16H 20/00 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
An insertion device (112) for inserting at least an insertable part of a medical device (110) into a body tissue (114) of a subject is proposed, comprising: - at least one housing (116) with at least one holding structure (118) adapted to releasably receive the medical device (110), - at least one insertion tool (120) configured for inserting at least the insertable part of the medical device, - at least one wheel (132) comprising a guiding structure (134) configured for guiding an axial movement of the insertion tool (120) and the holding structure (118) between a distal position and a proximal position, and - at least one torsional drive (146) configured for rotating the wheel (132) upon activation, wherein the guiding structure (134) comprises a shape with an eccentricity relative to a center of the wheel (132) and/or relative to a turning point of the wheel (132), wherein the eccentricity is unequal to zero, and wherein the shape is configured to slow a linear movement around a turning point of the insertion tool (120).
A computer-implemented method and system for predicting and displaying glucose values, including receiving CGM data, determining, based on the data, a plurality of first predicted glucose values (33) for a first prediction time window (30), determining, based on the data, that a hypoglycemia event is predicted to occur during a second prediction time window (31) which has a contemporaneous beginning with the first prediction time window (30) but is shorter than the first window (30), and determining a plurality of second predicted glucose values (34) for the second prediction time window (31) and displaying the plurality of second predicted glucose values (34) for the second prediction time window (31 ) while not displaying predicted glucose values subsequent to the second prediction time window (31).
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
G16H 40/60 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
G16H 50/50 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour la simulation ou la modélisation des troubles médicaux
78.
BODY MOUNT FOR MOUNTING AT LEAST ONE TRANSDERMAL MEDICAL DEVICE TO A BODY SURFACE OF A USER
A body mount (126) for mounting at least one transdermal medical device (128) to a body surface (130) of a user (132) is disclosed. The body mount (126) comprises: - at least one base element (134) having at least one mounting surface (136) for attachment to the body surface (130) of the user (132), - at least one capillary (138) for taking up blood from the body of the user (132) when the base element (134) is attached to the body surface (130) of the user (132); - at least one bleeding detector (150) configured for detecting blood in the capillary (138). Further disclosed are a medical device (124) comprising the body mount (126), a medical kit (164) comprising the medical device (124), a method of monitoring a transdermal medical device (128), and a method of determining at least one physiological parameter in a body tissue of a user (132) and computer programs and computer-readable storage media for performing the methods.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1473 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques invasifs, p. ex. introduits dans le corps par un cathéter
A61B 5/1455 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des capteurs optiques, p. ex. des oxymètres à photométrie spectrale
A61B 5/1459 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des capteurs optiques, p. ex. des oxymètres à photométrie spectrale invasifs, p. ex. introduits dans le corps par un cathéter
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61B 5/1495 - Étalonnage ou test des sondes in vivo
A61B 5/15 - Dispositifs de prélèvement d'échantillons de sang
A61B 5/157 - Dispositifs de prélèvement d'échantillons de sang caractérisés par des moyens intégrés pour mesurer des caractéristiques du sang
79.
COMPUTER-IMPLEMENTED METHODS FOR PREDICTING GLUCOSE VALUES, DATA PROCESSING SYSTEM, MEDICAL SERVER, AND USER DEVICE
The present disclosure refers to computer-implemented methods for predicting glucose values. Further, the present disclosure refers to a data processing system for predicting glucose values, a medical server, a user device, and a computer program.
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
G16H 40/60 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
G16H 50/50 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour la simulation ou la modélisation des troubles médicaux
80.
METHODS AND DEVICES FOR PROVIDING BLACKLIST INFORMATION ON THE SUITABILITY OF A MOBILE DEVICE FOR PERFORMING ANALYTICAL MEASUREMENTS
A computer-implemented method of operating a cloud server (114) for providing blacklist information, the method comprising: i. providing a cloud-based blacklist database (124) on the cloud server (114), the blacklist database comprising blacklist information on a plurality of mobile devices (112), each mobile device (112) having at least one camera (116), the blacklist information comprising information on the suitability of at least one of the mobile devices (112)' hardware and the mobile devices (112)' software for performing at least one analytical measurement; ii. providing, upon request by a requesting mobile device (112) of the plurality of mobile devices (112), at least one item of blacklist information from the blacklist database to the requesting mobile device (112), the blacklist information comprising information on the suitability of at least one of the requesting mobile device's hardware and the requesting mobile device's software for performing the at least one analytical measurement; iii. receiving at least one item of individual check result information from a sending mobile device (112) of the plurality of mobile devices (112), the item of check result information comprising information on the suitability of at least one of the sending mobile device's hardware and the sending mobile device's software for performing the at least one analytical measurement; iv. evaluating the item of individual check result information for the necessity of updating the blacklist information on the blacklist database.
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
G01N 21/00 - Recherche ou analyse des matériaux par l'utilisation de moyens optiques, c.-à-d. en utilisant des ondes submillimétriques, de la lumière infrarouge, visible ou ultraviolette
81.
OPTIMIZATION AND PERSONALIZATION OF THERAPEUTIC PROTOCOLS
Embodiments are described herein for optimizing and personalizing therapeutic protocols to treat a medical condition. An event of a therapeutic protocol may be determined. One or more triggering events may be detected for generating a notification associated with the event of the therapeutic protocol. The one or more triggering events may be determined to exceed a notification threshold indicating a level of confidence that a user will receive a notification transmitted in response to the one or more triggering events. The notification may be provided to a user to assist in treatment of a medical condition, such as a diabetic condition, in response to the detected triggering event associated with the event of the therapeutic protocol.
G16H 20/00 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
82.
OPTIMIZATION AND PERSONALIZATION OF THERAPEUTIC PROTOCOLS
Embodiments are described herein for optimizing and personalizing therapeutic protocols to treat a medical condition. An event of a therapeutic protocol may be determined. One or more triggering events may be detected for generating a notification associated with the event of the therapeutic protocol. The one or more triggering events may be determined to exceed a notification threshold indicating a level of confidence that a user will receive a notification transmitted in response to the one or more triggering events. The notification may be provided to a user to assist in treatment of a medical condition, such as a diabetic condition, in response to the detected triggering event associated with the event of the therapeutic protocol.
G16H 20/00 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
83.
INSERTION SYSTEM AND METHOD FOR INSERTING A MEDICAL DEVICE THECHNICAL FIELD
Insertion tool for inserting at least a part of a medical device into a subject, insertion device comprising the insertion tool and an insertion mechanism, and method for manufac- turing the insertion tool, wherein the insertion tool comprises a penetrating portion that com- prises a composite material comprising at least one first material and at least one second material, wherein the first material is an amorphous material or amorphous composite, the second material is a fibrillary material or fibrillary composite or a crystalline material or crystalline composite, a fluid absorption of the first material of the composite material is higher than a fluid absorption of the second material of the composite material, and the insertion device is adapted to soften when in contact with a body fluid at least due to the fluid absorption of the amorphous material or amorphous composite.
A61L 31/12 - Matériaux composites, c.-à-d. en couches ou contenant un matériau dispersé dans une matrice constituée d'un matériau analogue ou différent
A61L 31/14 - Matériaux caractérisés par leur fonction ou leurs propriétés physiques
A61M 5/32 - AiguillesParties constitutives des aiguilles relatives au raccordement de celles-ci à la seringue ou au manchonAccessoires pour introduire l'aiguille dans le corps ou l'y maintenirDispositifs pour la protection des aiguilles
A61M 25/06 - Aiguilles avec un guide pour piquer le corps ou analogues
A61M 37/00 - Autres appareils pour introduire des agents dans le corpsPercutanisation, c.-à-d. introduction de médicaments dans le corps par diffusion à travers la peau
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
tutu), wherein the locking member (124) is configured for holding the medical device holding structure (120) and the insertion component (122) in the distal position; and - at least one pusher (126) configured for applying an external force to overcome the predefined tensile strength of the locking member (124).
A61B 5/151 - Dispositifs de prélèvement d'échantillons de sang spécialement adaptés pour le prélèvement d'échantillons de sang capillaire, p. ex. par des lancettes
85.
BATTERY RELAXATION WITH NON-CONFORMING BLUETOOTHR COMMUNICATION BEHAVIOR
A computer implemented method for conserving power during BLUETOOTH® communication performed by a BLUETOOTH® enabled peripheral computing device, the method comprising advertising availability of the BLUETOOTH® enabled peripheral computing device for pairing, receiving a scan request from a BLUETOOTH® enabled central computing device, transmitting a scan response to the BLUETOOTH® enabled central computing device in response to the scan request, establishing a connection with the BLUETOOTH® enabled central computing device, monitoring a power consumption indicator of the peripheral computing device, introducing a delay period to a response period to a connection event received from the central computing device if the monitored power consumption indicator meets at least one predefined criteria, and wherein the delayed response period causes the response to occur after a predetermined peripheral latency period but prior to a supervision timeout.
An analytical system and an analytical method of determining at least one property of at least one sample of a bodily fluid are disclosed. The method comprises using at least one first mobile device (112) and at least one second mobile device (114), each of said mobile devices (112, 114) comprising at least one camera (116) and at least one processor (118). At least one first image is captured by the first mobile device (112) before applying the sample of the bodily fluid to a reagent test region (122). The first image is stored together with one time stamp and at least one first item of identity information in a database (128). The second mobile device (114) captures at least one second image and determines by using the stored information of the first mobile device (112) in the database (128) the at least one property of the sample.
A computer implemented method for conserving power during BLUETOOTH® communication performed by a BLUETOOTH® enabled peripheral computing device, the method comprising advertising availability of the BLUETOOTH® enabled peripheral computing device for pairing, receiving a scan request from a BLUETOOTH® enabled central computing device, transmitting a scan response to the BLUETOOTH® enabled central computing device in response to the scan request, establishing a connection with tire BLUETOOTH® enabled central computing device, monitoring a power consumption indicator of the peripheral computing device, introducing a delay period to a response period to a connection event received from the central computing device if the monitored power consumption indicator meets at least one predefined criteria, and wherein the delayed response period causes the response to occur after a predetermined peripheral latency period but prior to a supervision timeout.
A computer-implemented method of determining a numerical analyte result value corresponding to a concentration of an analyte in a sample of a bodily fluid of a subject applied to a reagent test region, comprising step (a) determining a numerical analyte result value based on an image of the reagent test region by using an algorithm which takes into account one or more parameters, each parameter being adapted to take more than one value, step (b) displaying the numerical analyte result value and/or a corresponding analyte value range and/or a corresponding message on a display device and step (c) automatically checking for available updated values for one or more of the parameters on a remote server before executing step (a), and for each available updated value updating the corresponding parameter value to be taken into account in step (a).
G16H 10/40 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données relatives aux analyses de laboratoire, p. ex. pour des analyses d’échantillon de patient
89.
METHOD FOR ENHANCED DETERMINATION OF ANALYTE CONCENTRATION IN BODILY FLUID
The present invention relates to medical device for detecting at least one analyte in a body fluid, comprising a base body for attaching the medical device to a patient's body; an insertable analyte sensor comprising an insertable portion; and an electronics unit operably connected to the insertable analyte sensor, wherein the insertable analyte sensor comprises a first electrode and a second electrode, both, forming part of the insertable portion, wherein the first electrode extending from a second end towards its first free end and the second electrode extending from a second end towards its first free end are configured to be, during use of the medical device, at least partially in electric contact with the body tissue of a user. In order to mitigate a risk of an uncontrolled electric current flowing into a user's body, the electrical resistance of the first and second electric conductor is higher than the electrical resistance of the first electrode and second electrode.
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
The present invention relates to a medical dispensing device comprising a first cylindrical reservoir, a second cylindrical reservoir, a first plunger movably arranged within the first cylindrical reservoir, a second plunger movably arranged within the second cylindrical reservoir, and a drive that is configured for moving the first plunger within the first cylindrical reservoir and that is further configured for moving the second plunger within the second cylindrical reservoir. For an improved dosing accuracy, the drive is configured to selectively move either the first plunger or the second plunger, and in that the drive is further configured to stop moving the first plunger within the first cylindrical reservoir when the first plunger reaches the ending point within the first cylindrical reservoir, and to start moving the second plunger within the second cylindrical reservoir.
A61M 5/14 - Dispositifs de perfusion, p. ex. perfusion par gravitéPerfusion sanguineAccessoires à cet effet
A61M 5/145 - Perfusion sous pression, p. ex. utilisant des pompes utilisant des réservoirs sous pression, p. ex. au moyen de pistons
A61M 5/168 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte
A61M 5/20 - Seringues automatiques, p. ex. avec tige de piston actionnée automatiquement, avec injection automatique de l'aiguille, à remplissage automatique
92.
MEDICAL INFUSION DEVICE SYSTEM HAVING A DOSING RANGE EXTENSION
The present invention relates to a medical infusion device system comprising a first dosing chamber for delivering at least a first minimum dosing amount of a liquid medicament, a second dosing chamber for delivering at least a second minimum dosing amount of the liquid medicament, a fluid line operatively coupled to the first dosing chamber and the second dosing chamber for conveying a total amount of liquid medicament for delivering by the first and second dosing chamber to an outlet of the fluid line, and a controller to control the total amount of liquid medicament. In order to provide relatively small and large dosing amounts both fast and accurate the second minimum dosing amount of the liquid medicament provided by the second dosing chamber larger than the first minimum dosing amount of the liquid medicament provided by the first dosing chamber.
A61M 5/145 - Perfusion sous pression, p. ex. utilisant des pompes utilisant des réservoirs sous pression, p. ex. au moyen de pistons
A61M 5/168 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte
A61M 5/14 - Dispositifs de perfusion, p. ex. perfusion par gravitéPerfusion sanguineAccessoires à cet effet
A61M 5/20 - Seringues automatiques, p. ex. avec tige de piston actionnée automatiquement, avec injection automatique de l'aiguille, à remplissage automatique
A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
93.
INSERTION SYSTEM AND METHOD FOR INSERTING A MEDICAL DEVICE
An insertion device for inserting at least part of a medical device into a subject comprising a chamber for receiving the medical device, an insertion tool for inserting an insertable portion of the medical device, an insertion mechanism, a retraction mechanism for retracting the insertion tool from the subject after insertion, a retaining mechanism for retaining the insertion tool in an end position after retraction, an inner housing comprising the retaining mechanism and the retracted insertion tool in the end position, an inserter housing comprising the insertion mechanism as well as a chamber for receiving the inner housing, wherein the inserter housing is formed of recyclable or biodegradable or compostable material, the insertion device comprises an ejection mechanism to remove the inner housing from the chamber when the insertion tool is retrained within the inner housing by the retaining mechanism, and the ejection mechanism is activatable by the user.
The present invention relates to a filling apparatus for filling a reusable reservoir of a medical dispensing device, the filling apparatus comprises a receiving portion for a reusable reservoir, a supply container for containing a liquid medication, a first connection port for fluidly connecting an inner volume of the reusable reservoir with the supply container, and a sterilization device that is configured for sterilizing the inner volume of the reusable reservoir. In order to provide an improved sterilization, the filling apparatus further comprises a discharging device for discharging deposit from the inner volume of the inner volume, wherein the sterilization device comprises a radiation source for providing a radiation for sterilizing the reusable reservoir. The reusable reservoir is housed in a radiation chamber.
The present invention relates to a method (200) of continuously in vivo detecting at least one analyte in a bodily fluid over a time span, an analyte sensor system (100) for in vivo continuously detecting at least one analyte in a bodily fluid over a measurement time span, a computer program and a computer-readable storage medium. The method (200) makes use of at least one analyte sensor (102) comprising at least one working electrode (104), configured for performing at least one electrochemical detection reaction with the analyte, and at least one further electrode (106), the further electrode (106) comprising at least one redox material composition, the redox material composition comprising silver and silver chloride, the method (200) comprising the following steps: monitoring at least one standard sensor signal (132) derived by using the analyte sensor (102) in a standard operation mode, comparing the standard sensor signal (132) with at least one threshold, thereby determining if a change of an operation mode of the analyte sensor (102) from the standard operation mode into an economy operation mode is required.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1473 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques invasifs, p. ex. introduits dans le corps par un cathéter
A61B 5/1495 - Étalonnage ou test des sondes in vivo
96.
MEDICAL INFUSION DEVICE COMPRISING A LEAKAGE DETERMINING MODULE
The present invention relates to a medical infusion device comprising a reservoir for holding a liquid medicament, a cannula assembly, a fluid line, a drive mechanism, a dispensing member for dispensing medicament from reservoir through the fluid line and the cannula assembly, and a leakage determining module. For a more convenient determination of leakage of liquid medicament, the leakage determining module comprises an electronic probe that is configured for receiving odor molecules and/or flavor molecules of the liquid medicament and in that the leakage determining module further comprises evaluation electronics that is configured to determine presence of odor and/or flavor of the liquid medicament based on readings of the at least one electronic probe.
The present disclosure refers to computer-implemented method and healthcare management system for providing a personalized healthcare parameter. The method is comprising the following: providing a healthcare application (20), and an interface application (25) running in a data processing component having a plurality of data processors; submitting, from the healthcare application (20) to the interface application (25), a service request indicative of a request for determining a first personalized healthcare parameter, the first personalized healthcare parameter being indicative of a first healthcare condition of the patient; in response to receiving the service request, generating a first input data request by the interface application (25); providing the first input data request to a first service application (26a) from a plurality of service applications, wherein each of the service applications (26) is configured to determine, for a patient, a respective personalized healthcare parameter in response to receiving respective personalized input data, and the first service application (26a) is configured to determine the first personalized healthcare parameter; receiving first input data information in the interface application (25), the first input data information being indicative of a data specification of first input data required by the first service application (26a) for determining the first personalized healthcare parameter; receiving the first input data information in the healthcare application (20); generating first personalized input data in the healthcare application (20), the first personalized input data being generated according to the first input data information; receiving the first personalized healthcare parameter in the healthcare application (20), wherein the first personalized healthcare parameter was determined in response to receiving the first personalized input data in the first service application (26a), such determining comprising processing the first personalized input data; and outputting the first personalized healthcare parameter to a receiving device (27; 28) connected to the data processing component (2).
G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
Analyte sensor morphology The invention relates to an analyte sensor for use in medical devices for measuring analyte data in an analyte carrying fluid, in particular for measuring glucose data, comprising: a first electrode (101) being a working electrode, a second electrode, a substrate (100) carrying the first electrode and the second electrode, at least one membrane (104) which at least partially covers the first electrode (101), wherein the at least one membrane (101) comprises a membrane material that is impermeable to the analyte carrying fluid and/or the analyte, wherein the at least one membrane comprises at least one opening (107), and wherein the at least one membrane (104) is configured for controlling the flux of the analyte carrying fluid and/or the analyte to the first electrode (101) via the at least one opening (107).
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
A61B 5/1473 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques invasifs, p. ex. introduits dans le corps par un cathéter
A61B 5/1486 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques en utilisant des électrodes enzymatiques, p. ex. avec oxydase immobilisée
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
99.
METHOD OF DETERMINING A FINAL NUMERICAL ANALYTE RESULT VALUE CORRESPONDING TO A CONCENTRATION OF AN ANALYTE IN A BODILY FLUID USING A MOBILE DEVICE
A method of determining an analyte concentration in a bodily fluid using a mobile device with a camera, as well as a corresponding computer program, a non-transitory computer- readable storage medium with corresponding instructions, a corresponding mobile device, and a corresponding kit. The method comprises step a: determining a numerical analyte result value from an image of a color formation of a reagent test region, step b: displaying the numerical analyte result value and/or a corresponding analyte value range and/or a corresponding message, wherein in a step c) after step a) and before step b) an upper bias is added to the numerical analyte result value if it exceeds an upper threshold value, or a lower bias is subtracted if it falls below a lower threshold value, or it is kept unchanged it neither threshold value is passed.
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
G01N 21/78 - Systèmes dans lesquels le matériau est soumis à une réaction chimique, le progrès ou le résultat de la réaction étant analysé en observant l'effet sur un réactif chimique produisant un changement de couleur
G01N 21/84 - Systèmes spécialement adaptés à des applications particulières
G01N 33/52 - Utilisation de composés ou de compositions pour des recherches colorimétriques, spectrophotométriques ou fluorométriques, p. ex. utilisation de bandes de papier indicateur
100.
METHOD OF INDIVIDUALIZING ANALYTE VALUE RANGES USED TO CATEGORIZE A CONCENTRATION OF AN ANALYTE
A method of individualizing analyte value ranges used to categorize a concentration of an analyte in a sample of a bodily fluid of a subject applied to a reagent test region and determined using a mobile device having a processing device, as well as a corresponding computer program, a non-transitory computer-readable storage medium with corresponding instructions, a corresponding mobile device, and a corresponding kit. The method comprises the steps of determining a numerical analyte result value from an image of a color formation of the reagent test region, attributing the numerical analyte result value to a corresponding analyte value range, and adapting one or more range limit values based on a plurality of numerical analyte result values previously determined for different samples of the subject's bodily fluid taken at different points in time.
G01N 21/78 - Systèmes dans lesquels le matériau est soumis à une réaction chimique, le progrès ou le résultat de la réaction étant analysé en observant l'effet sur un réactif chimique produisant un changement de couleur
G01N 21/84 - Systèmes spécialement adaptés à des applications particulières
G16H 10/40 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données relatives aux analyses de laboratoire, p. ex. pour des analyses d’échantillon de patient
G16H 30/20 - TIC spécialement adaptées au maniement ou au traitement d’images médicales pour le maniement d’images médicales, p. ex. DICOM, HL7 ou PACS
G16H 30/40 - TIC spécialement adaptées au maniement ou au traitement d’images médicales pour le traitement d’images médicales, p. ex. l’édition
G16H 50/70 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour extraire des données médicales, p. ex. pour analyser les cas antérieurs d’autres patients
G01N 21/77 - Systèmes dans lesquels le matériau est soumis à une réaction chimique, le progrès ou le résultat de la réaction étant analysé en observant l'effet sur un réactif chimique
brevets
